- Home
- ETON vs LEGH Comparison
ETON vs LEGH Comparison
Compare ETON & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | LEGH |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.8M | 495.0M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ETON | LEGH |
|---|---|---|
| Price | $16.27 | $19.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $29.67 | $25.00 |
| AVG Volume (30 Days) | ★ 211.3K | 116.0K |
| Earning Date | 11-06-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.95 |
| Revenue | $70,316,000.00 | ★ $180,497,000.00 |
| Revenue This Year | $107.23 | N/A |
| Revenue Next Year | $29.72 | $6.07 |
| P/E Ratio | ★ N/A | $9.89 |
| Revenue Growth | ★ 102.77 | 10.25 |
| 52 Week Low | $11.09 | $18.84 |
| 52 Week High | $23.00 | $29.45 |
Technical Indicators
Market Signals| Indicator | ETON | LEGH |
|---|---|---|
| Relative Strength Index (RSI) | 45.11 | 36.44 |
| Support Level | $16.53 | $19.56 |
| Resistance Level | $17.33 | $19.95 |
| Average True Range (ATR) | 0.64 | 0.54 |
| MACD | 0.08 | -0.02 |
| Stochastic Oscillator | 32.91 | 11.43 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.